• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

CELL CYTOTOXICITY OF IMMUNOGLOBULINS FROM AMYOTROPHIC LATERAL SCLEROSIS ON VARIOUS NERVOUS CELL LINES

Research Project

Project/Area Number 06670676
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Neurology
Research InstitutionOSAKA MEDICAL COLLEGE

Principal Investigator

KIMURA Fumiharu  OSAKA MECLICAL COLLEGE ASSISTANT, 医学部, 助手 (90204990)

Co-Investigator(Kenkyū-buntansha) ISHIDA Simon  OSAKA MEDICAL COLLEGE RESEARCH FELLOW, 医学部, 専攻手医
NAKAJIMA Hideto  OSAKA MEDICAL COLLEGE RESEARCH FELLOW, 医学部, 専攻手医
ITO Takumi  OSAKA MEDICAL COLLEGE RESEARCH FELLOW, 医学部, 専攻手医
YAMASAKI Hidetomo  OSAKA MEDICAL COLLEGE RESEARCH FELLOW, 医学部, 専攻手医
FURUTAMA Daisuke  OSAKA MEDICAL COLLEGE RESEARCH FELLOW, 医学部, 専攻手医
篠田 恵一  大阪医科大学, 医学部, 助手 (60187367)
Project Period (FY) 1994 – 1995
Project Status Completed (Fiscal Year 1995)
Budget Amount *help
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1995: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1994: ¥1,100,000 (Direct Cost: ¥1,100,000)
KeywordsALS / apoptosis / VSC 4.1 / PC 12 / Dihydropyridine / 1g G / VGCC / Campylobacter jejuni / Apoptosis / PC12 / IMR-32 / Calbindin D-28K / autoimmuhe
Research Abstract

1) Prior studies demonstrated that most patients with sporadic ALS possess immunoglobulins that bind to purified L-type voltage gated calcium channel (VGCC). Using Western transfer and Enzyme-Linked Immunosorbent Assay, alpha 1 subunit of VGCC is now identified as the major VGCC antigen to which ALS IgG binds. In addition, VGCC-binding IgG from patients with Lambert-Eaton myasthenic syndrome appears to be differentiated from ALS IgG by the reactivity of the former to both alpha 1 and beta subunits of VGCC.Aprimary role for ALS IgG in disease pathogenesis might also be suggested because selective antibody binding to exposed extracellular VGCC epitopes is found.
2) VGCC-enriched subsarcolemmal membrane fractions were prepared from biopsied quadriceps muscle of patients with ALS,without apparent neuromuscular disease, and tested for DHP binding with [3H] PN200-110. ALS muscle VGCCs possessed eightfold higher binding affinities for [3H] PN200-110 than did VGCCs from muscle fractions of othe … More r patients, independent of denervation-induced increases in DHP binding site number. Similarly elevated DHP binding affinities were observed in specimens from patients with autoimmune motor neuropathies, suggesting that ALS and immune mediated motoneuron disease share skeletal muscle L-type VGCC alterations.
3) There was no cytotoxic effect of ALS IgG (1mg/ml) on high K^+ stimulated neurite bearing cell expansion rate of PC 12 cell in which neurite growth of PC12 is dependent to Ltype Ca channel, confirmed by the inhibition of nifedipine.
4) We reported two Guillain-Barre syndrome (GBS) patients with culture-proven Campylobacter jejuni (Penner 19, Lior 7). Elevated anti-C.jejuni IgA antibody declined to the normal range within one month, elevation of anti-C.jejuni IgM antibody lasted for 3 month, and the titers of anti-C.jejuni IgG antibody was still elevated at one year after the neurologic onset. Serological criteria for antecedent C.jejuni infection in GBS patients should require 1) high titer of serum IgA and/or IgM antibody against C.jejuni followed by seroconversion of the, IgA and/or IgM 2) a 4-fold decline of IgG serum dilution against C.jejuni. Anti-C.jejuni antibodies in CSF reached to the maximum value at one month after their neurologic onset which may not be responsible for a main pathomechanism at development of GBS.The levels of anti-GM1 antibodies in seurm and CSF were paralleled with those of anti-C.jejuni antibodies. Less

Report

(3 results)
  • 1995 Annual Research Report   Final Research Report Summary
  • 1994 Annual Research Report
  • Research Products

    (24 results)

All Other

All Publications (24 results)

  • [Publications] F. Kimura et al.: "ALS antibodies label Ca^<2+> channel α,subunit" Ann. Neurol. 35. 164-171 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] RG. Smith, et al: "Altered muscle calcium channel binding Kinetics in auto in mune motoneuron disease" Muscle Nerve. 18. 620-627 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] F. Kimura: "Longitudinal study of serum and CSF class-specific antibodies ajaint Campyloboter Jejuju and GM1 in Gulla punvi sydine" Intern Med. 34. 1009-1014 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] 木村文治: "自己免疫性神経細胞死におけるアポトーシスの可能性について" 診断と治療. 82. 137-141 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] 木村文治: "神経細胞死におけるApoptosisの可能性について(II)-筋萎縮性側索硬化症を中心に-" 診断と治療. 83. 127-132 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] 石田志門: "血漿交換療法が著効を示したキャンピロバクター感染後抗GM1抗体陽性ギランバレー症候群の一例" 免疫薬理. 12. 437-440 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] F. Kimura, et al.: "In ALS: Progress and perspectives in basic research" Flsevir, Amsterdam, (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] F.Kimura, RG.Smith, et al: "Amyotrophic lateral sclerosis antibodies label Ca2+ channel alpha 1 subunit." Ann Neurol. 35. 164-171 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] RG.Smith, F.Kimura, et al: "Altered muscle calcium channel binding kinetics in autoimmune motoneuron disease." Muscle Nerve. 18. 620-7 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] F.Kimura, RG.Smith, et al: "The specific antibody against alpha 1 subunit of Ca2+ channel in sporadic amyotrophic lateral sclerosis." In Amyotrophic Lateral Sclerosis : .Progress and perspectives in basic reseasrch and clinical application, Elsevier, Amsterdam. (in print). (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] F.Kimura, T Ito.et al: "Longitudinal Study of Serum and Cerebrospinal Fluid Class-specific Antibodies agaist Campylobacter Jejuni and GM1 Ganglioside in Guillain-Barre Syndrome." Inetrn Med. 34. 1009-1014 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] F.Kimura, et al: "The possibility of apoptosis on autoimmune nuerve cell death (I) -paraneoplastic cerebellar degeneration-" Diagnosis and therapy. 82. 137-141 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] F.Kimura, et al: "The possibility of apoptosis on central nuerve cell death (II) -Amyotrophic lateral sclerosis-" Diagnosis and therapy. 83. 127-132 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] S.Ishida, et al: "The beneficial effect of plasmapheresis in a Guillain-Barre Syndrome. pathient following Campylobacter Jejuni with GM1 Ganglioside" Men-eki Yakuri. 12. 437-440 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] F. Kimura: "Amyotrophic lateral sclerosis antibodies label Ca chamel" Ann. Newrology. 35. 164-171 (1994)

    • Related Report
      1995 Annual Research Report
  • [Publications] F. Kimura: "Altered muscle calcium channel binding linetics inaitoimmeue motooeurn dis." Muscle-Nerve. 18. 620-627 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] F. Kimura: "The specific autibody to DHP receptor of calcium channel in anyotnplicic lateul sclessc" 「ALS」prigoss and perspectioes in basic Rasearch. in-print (1996)

    • Related Report
      1995 Annual Research Report
  • [Publications] F. Kimura: "long tudnul study of seram and CSF dass-speific Antiboctis against Compyrobacter Jejuni and GM, gaudli of icle in GBS" Intern. Med. 34. 1009-1014 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] H.Nakajima: "Transcriptional activcetion of the androgon receptor in X-linked sBMA." J. Neurol. Sci. in print (1996)

    • Related Report
      1995 Annual Research Report
  • [Publications] 木村 文治: "自己免疫性神経細胞死におけるアポトーシスの可能性について" 診断と治療. 82. 137-141 (1994)

    • Related Report
      1995 Annual Research Report
  • [Publications] 木村 文治: "神経細胞死におけるapoidtosisの可能性(2)-ALSを中心に-" 診断と治療. 83. 127-132 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] F.Kimura: "Amyotrophic laterul Sclerosis patiaut antibsdies label Ca^<2+> chaxnld,sufcir" Ann Neurol. 35. 164-171 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] 木村文治: "神経細胞死における“Apoptosis"の可能性について" 診断と治療. 83. 127-136 (1995)

    • Related Report
      1994 Annual Research Report
  • [Publications] F.Kimura: "The lngitudinul study of sesrem adcsfartilxdies a piust carpylihactes jejddri and GM, gaugliosides is Guillaes Dune syndrome" Intorn Med.(in print). (1995)

    • Related Report
      1994 Annual Research Report

URL: 

Published: 1994-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi